Losing fat, especially stubborn areas, is difficult because your brain fights hunger while your body holds onto stored energy. GLP receptor agonists (semaglutide, tirzepatide, and retatrutide) powerfully reduce appetite and calorie intake. AOD-9604, a fragment of growth hormone, helps mobilize and break down stored fat. Many combine them hoping for better results than either alone: GLPs create the calorie deficit, while AOD helps the body actually release and burn fat. No large primary trials test the exact stack, but individual studies support complementary mechanisms. This article uses peer-reviewed clinical data.
What Are These Compounds?
- Semaglutide (Wegovy/Ozempic): GLP-1 receptor agonist.
- Tirzepatide (Mounjaro/Zepbound): Dual GLP-1/GIP agonist.
- Retatrutide: Triple agonist (GLP-1/GIP/glucagon) — currently in late-stage trials.
- AOD-9604: The last 16 amino acids of human growth hormone, selected for its fat-burning effects without raising IGF-1 or strongly affecting blood sugar.
The stack idea: GLPs handle strong appetite suppression and overall weight loss; AOD-9604 adds targeted fat mobilization for potentially better body composition.
GLP Agonists: Powerful Appetite Suppression and Weight Loss
These medications mimic gut hormones that signal fullness and slow digestion.
- Semaglutide (STEP 1 trial): ~14.9% average body weight loss over 68 weeks (vs. 2.4% placebo). The SELECT trial also showed major cardiovascular benefits.
- Tirzepatide (SURMOUNT-1): Up to 20–21% weight loss at the highest dose over 72 weeks, often outperforming semaglutide.
- Retatrutide (phase 2/3 data): Up to 24%+ weight loss with continued fat reduction and strong metabolic improvements due to added glucagon action.
Common side effects are mostly mild-to-moderate stomach issues that improve with time.
AOD-9604: Fat Mobilization Specialist
AOD-9604 stimulates lipolysis (fat breakdown) in fat cells. In human trials involving over 900 people, it was safe with very few side effects and no significant rise in IGF-1 or blood sugar changes. Early studies showed modest extra weight loss (roughly 2–3 kg more than placebo over 12 weeks in some groups). It appears most helpful for supporting the release of stored fat during a calorie deficit rather than causing large standalone weight loss.
Why Stack Them? Strong Synergistic Potential
- GLPs dramatically lower hunger and calorie intake, creating a large energy deficit.
- AOD-9604 helps the body mobilize and burn stored fat (especially stubborn areas) during that deficit.
Together they address two key barriers to fat loss: eating less (GLPs) and actually releasing fat stores (AOD). Clinics often report improved body composition — more fat loss with better muscle preservation — compared to GLPs alone. The mechanisms complement each other perfectly, and real-world use is growing for people seeking enhanced results.
Important Caveats from the Science
Semaglutide and tirzepatide have the strongest, largest human evidence and are FDA-approved for weight management. Retatrutide is very promising but still investigational. AOD-9604 has a good safety record but showed only modest or inconsistent added weight loss in larger trials. Long-term safety of the unregulated stack is unknown, and compounded AOD quality varies. Please know your source when getting AOD or retatrutide. These are powerful tools — not magic — and work best with protein-rich diet, resistance training, and medical supervision. Always consult a doctor before combining them.
The Bottom Line
Primary studies show GLP agonists (semaglutide, tirzepatide, retatrutide) deliver impressive appetite suppression and 15–24%+ weight loss in large trials, while AOD-9604 supports direct fat mobilization with a clean safety profile. As a synergistic stack, they combine powerful hunger control with enhanced fat release for more effective and potentially better-composition fat loss. Promising approach for stubborn fat and body recomposition, but more rigorous human combination trials are still needed. Science continues to advance smarter ways to help people achieve sustainable fat loss and metabolic health.
This information is not medical advice. Results vary by individual, and these compounds should be used only under the supervision of a qualified healthcare provider with appropriate monitoring (including regular bloodwork). They are not substitutes for a healthy diet, exercise, sleep, or standard medical care. Always consult your doctor before starting any peptide or compounded regimen.
